title: Psoriatic exacerbation associated with insulin therapy.
authors.forename: Allan F
authors.initials: AF
authors.lastname: Moore
authors.forename: Tiffany
authors.initials: T
authors.lastname: Soper
authors.forename: Natalie
authors.initials: N
authors.lastname: Jones
authors.forename: Joop
authors.initials: J
authors.lastname: Grevelink
authors.forename: Nicolas
authors.initials: N
authors.lastname: Abourizk
mesh_terms: D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D011565:Psoriasis / Q000503:physiopathology*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine; D008687:Metformin